Rita Keynan
Corporate Officer/Principal chez PAINREFORM LTD.
Profil
Rita Keynan is currently the Vice President-Pharmaceutical Operations at PainReform Ltd.
Her former job was as the Executive Director-Drug Development at VYNE Pharmaceuticals Ltd.
She received her undergraduate and graduate degrees from The Hebrew University of Jerusalem.
Postes actifs de Rita Keynan
Sociétés | Poste | Début |
---|---|---|
PAINREFORM LTD. | Corporate Officer/Principal | 06/01/2021 |
Anciens postes connus de Rita Keynan
Sociétés | Poste | Fin |
---|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Corporate Officer/Principal | - |
Formation de Rita Keynan
The Hebrew University of Jerusalem | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PAINREFORM LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |